Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|January 4, 2024
Case report: A case of fulminant type 1 diabetes mellitus after COVID-19 vaccination during treatment of advanced gastric cancer: pitfall in managing immune-related adverse eventsToshimitsu Tanaka, Sachiko Nagasu, Takuya Furuta, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 21, 2018
[A Case of Postoperative Recurrence of Rectal Cancer in Which Desensitization Therapy Was Effective against Oxaliplatin Allergy in L-OHP]Mitsuhiro Katagiri, Keisuke Miwa, Susumu Shimomura, et al.
Nutrients|July 1, 2020
Profiles Combining Muscle Atrophy and Neutrophil-to-Lymphocyte Ratio Are Associated with Prognosis of Patients with Stage IV Gastric CancerKota Shigeto, Takumi Kawaguchi, Shunji Koya, et al.
Japanese Journal of Clinical Oncology|August 9, 2012
Hypomanic episode during recurrent gastric cancer treatment: report of a rare case and literature reviewMototsugu Matsunaga, Hideki Onishi, Mayumi Ishida, et al.
Medicine|May 20, 2021
A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancerMasaru Fukahori, Keisuke Miwa, Kenta Murotani, et al.
Annals of Nuclear Medicine|March 18, 2022
Efficacy of myocardial washout of 99mTc-MIBI/Tetrofosmin for the evaluation of inflammation in patients with cardiac sarcoidosis: comparison with 18F-fluorodeoxyglucose positron emission tomography findingsMasataka Suzuki, Yu Izawa, Hiroshi Fujita, et al.
Japanese Journal of Clinical Oncology|February 12, 2011
Regimen selection for first-line FOLFIRI and FOLFOX based on UGT1A1 genotype and physical background is feasible in Japanese patients with advanced colorectal cancerHiroo Ishida, Ken-Ichi Fujita, Yuko Akiyama, et al.
Oncology Reports|July 14, 2005
Antineoplaston induces G(1) arrest by PKCalpha and MAPK pathway in SKBR-3 breast cancer cellsTeruhiko Fujii, Anna M Nakamura, Goro Yokoyama, et al.
Oncology Reports|July 3, 2010
Pharmacokinetics of S-1 and CYP2A6 genotype in Japanese patients with advanced cancerTakashi Hirose, Ken-Ichi Fujita, Kazuko Nishimura, et al.
Japanese Journal of Clinical Oncology|July 1, 2010
Clinical and economic evaluation of first-line therapy with FOLFIRI or modified FOLFOX6 for metastatic colorectal cancerHidetomo Ajima, Hiroyasu Ogata, Ken-ichi Fujita, et al.
Pageof 9